The global Embolic protection devices market accounted for US$ 436.2 million in 2020 and is estimated to be US$ 1020.3 million by 2030 and is anticipated to register a CAGR of 8.9%. Embolic protection devices (EPDs) are the most widely used during percutaneous cardiac operations. The use of embolic protection devices (EPD) during percutaneous cardiac procedures has helped to reduce the number of complications caused by debris being released into the bloodstream and causing blockages in smaller vessels. These devices are part of the best, most scientifically proven treatment for preventing periprocedural myocardial infarction and other major cardiovascular events. EPDs are classified as distal occlusion aspiration devices, distal filters, or proximal occlusion aspiration devices depending on their mechanism of action.